TEMA ETF TRUST - ONCOLOGY ETF (CANC)

CUSIP: 87975E701

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / ONCOLOGY ETF
Total 13F shares
972,874
Share change
+836,892
Total reported value
$24,053,732
Price per share
$24.72
Number of holders
5
Value change
+$20,692,004
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 87975E701?
CUSIP 87975E701 identifies CANC - TEMA ETF TRUST - ONCOLOGY ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CANC - TEMA ETF TRUST - ONCOLOGY ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of TEMA ETF TRUST - ONCOLOGY ETF (CANC) as of Q2 2025

As of 30 Jun 2025, TEMA ETF TRUST - ONCOLOGY ETF (CANC) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 972,874 shares. The largest 5 holders included Thrivent Financial for Lutherans, JANE STREET GROUP, LLC, RAYMOND JAMES FINANCIAL INC, OSAIC HOLDINGS, INC., and PRINCIPAL SECURITIES, INC.. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
6
Q2 2025 holders
5
Holder diff
-1
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .